Skip to main content

Osaka University Venture Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

46
Companies
$142.4M
Total invested
$3.1M
Avg. check
33
Industries
Biotechnology 8Medical Device 7Health Care 6Manufacturing 6Medical 6Artificial Intelligence (AI) 5+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 46
Celaid Therapeutics
October 2026

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

Biotechnology · Tokyo$2.5M Series B
Purmx Therapeutics
September 2026

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

Alternative Medicine · HiroshimaCorporate Round
Cykinso
September 2026

Cykinso is a developer of a home-testing kit designed to tell people the state of their intestinal bacteria.

Beauty · TokyoSecondary Market
JiMED
June 2026

JiMED designs and develops an AI-based brain-computer interface for implants in ALS patients to improve communication.

Artificial Intelligence (AI) · Suita$2.0M Venture - Series Unknown
Periotherapia
May 2026

Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.

Alternative Medicine · Osaka$6.8M Grant
FunPep
February 2026

FunPep is a biotechnology firm that develops functional cosmetics, medical supplies, and pharmaceutical drugs for people's well-being.

Biotechnology · Tokyo$5.5M Venture - Series Unknown
A-Wave
February 2026

A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.

Health Care · Osaka-shi$3.5M Series B
Immunosens
November 2025

Immunosens is a medical device company that develops immunosensors for immunological tests.

Biotechnology · SuitaVenture - Series Unknown
A-SEEDS
July 2025

A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

Biotechnology · Matsumoto$15.0M Series A
Ayumo
April 2025

Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.

Artificial Intelligence (AI) · Osaka$699K Seed
MiCAN Technologies
January 2025

MiCAN Technologies is a medical and nursing care company that offer cell design technology, and an evaluation system.

Health Care · Kyoto$1.6M Venture - Series Unknown
Alpha Fusion
October 2024

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

Medical · Osaka$6.9M Series B
Luxna Biotech
September 2024

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

Biotechnology · Osaka$1.7M Series C
Bioworks
January 2024

Bioworks is a fashion label that utilizes plax fiber in its manufacturing process.

Chemical · Kyoto$2.8M Venture - Series Unknown
GAIA BioMedicine
September 2021

GAIA BioMedicine is a biopharmaceutical company that specializes in innovative cell therapies and immunotherapies for treating solid tumors.

Biotechnology · Fukuoka$11.9M Series B
mediVR
July 2021

mediVR is a medical equipment that applies the video technology of virtual reality.

Artificial Intelligence (AI) · Osaka$4.6M Series B
LQUOM
October 2025

LQUOM is a quantum communication company developing systems, repeaters, and technologies to realize the quantum Internet.

Communications Infrastructure · YokohamaSeries B
SK Fine
April 2021

SK Fine is a production company that manufactures and sells ceramic molding parts, 3d printers, and photopolymerization equipment products.

3D Technology · Kusatsu$2.3M Seed
HULIX Technologies
January 2021

HULIX Technologies focuses on the development, construction, and sales of human flow space analysis platforms.

Artificial Intelligence (AI) · Osaka$1.2M Seed
AFI Technology
January 2021

AFI Technology is a biotechnology company that specializes in the development, control, and sale of regenerative medicine.

Biotechnology · KyotoSeries Unknown
Cotobadeslgn
October 2020

Cotobadeslgn is a dialogue content development company that develops a platform to interact with advanced AI technology.

Artificial Intelligence (AI) · Tokyo$949K Series Unknown

Where Osaka University Venture Capital invests

Biotechnology8
Medical Device7
Health Care6
Manufacturing6
Medical6
Artificial Intelligence (AI)5

About Osaka University Venture Capital's portfolio

How many companies has Osaka University Venture Capital invested in?▸

Osaka University Venture Capital has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Osaka University Venture Capital invest in?▸

Osaka University Venture Capital's top investment sectors include Biotechnology, Medical Device, Health Care, Manufacturing, Medical. The firm invests across 33 different industry categories.

What is Osaka University Venture Capital's largest investment?▸

Among tracked funding rounds, A-SEEDS received $15.0M in a Series A round. Osaka University Venture Capital's total known invested capital is $142.4M.

What is the average investment size for Osaka University Venture Capital?▸

Osaka University Venture Capital's average investment size is $3.1M across its portfolio of 46 companies.

What are Osaka University Venture Capital's most recent investments?▸

Recent Osaka University Venture Capital portfolio additions include Celaid Therapeutics, Purmx Therapeutics, Cykinso, JiMED, Periotherapia. These companies were founded in 2020 or later.

Reach the founders behind these 46 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →